← Leaderboards
Myra A Lipes
Joslin Diabetes Center
$9,219,490
Attributed
$9,219,490
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $864.7K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$9,219,490 · 8
By mechanism
R01$8,175,097 · 6
P01$722,686 · 1
P30$321,707 · 1
Top collaborators
No co-investigators on record.
Most similar at Joslin Diabetes Center
Same institution · by research overlap
- Steven E Shoelson$31,318,982
- Persis Commissariat$379,068
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusGenetically Modified AnimalsInsulinInsulin Dependent Diabetes MellitusNod MouseDisease /Disorder ModelPancreatic IsletsGlucokinaseLaboratory MouseT-LymphocyteCardiac MyosinsAutoantibodiesAutoimmune DiseasesCardiacAutoimmunityRisk FactorsCell InjuryMorbidity - Disease RateCardiovascular DiseasesCardiovascular Disorder RiskHyperglycemiaDisease OutcomeMyocardial InfarctionAdenoviridae
Grant awards (32)
Cardiac Autoimmunity as a Mediator of Cardiovascular Outcomes in Type 1 Diabetes$370,243
R01 · FY2022 · DK · contact PI
Cardiac Autoimmunity as a Mediator of Cardiovascular Outcomes in Type 1 Diabetes$378,162
R01 · FY2021 · DK · contact PI
Cardiac Autoimmunity as a Mediator of Cardiovascular Outcomes in Type 1 Diabetes$392,786
R01 · FY2020 · DK · contact PI
Cardiac Autoantibodies as Biomarkers for Heart Disease in Type 1 Diabetes$372,977
R01 · FY2018 · DK · contact PI
Cardiac Autoantibodies as Biomarkers for Heart Disease in Type 1 Diabetes$377,739
R01 · FY2017 · DK · contact PI
Cardiac Autoantibodies as Biomarkers for Heart Disease in Type 1 Diabetes$372,330
R01 · FY2016 · DK · contact PI
Autoimmune Mechanisms in the Progression of CVD in Type 1 Diabetes$392,933
R01 · FY2009 · DK · contact PI
Autoimmune Mechanisms in the Progression of CVD in Type 1 Diabetes$383,217
R01 · FY2008 · DK · contact PI
Molecular Mechanisms of Autoimmune Heart Disease$465,832
R01 · FY2007 · HL · contact PI
Autoimmune Mechanisms in the Progression of CVD in Type 1 Diabetes$381,413
R01 · FY2007 · DK · contact PI
Molecular Mechanisms of Autoimmune Heart Disease$466,702
R01 · FY2006 · HL · contact PI
Autoimmune Mechanisms in the Progression of CVD in T1D$383,181
R01 · FY2006 · DK · contact PI
Molecular Mechanisms of Autoimmune Heart Disease$464,959
R01 · FY2005 · HL
Autoimmune Mechanisms /Progression of CVD in Type 1 Diab$399,771
R01 · FY2005 · DK
A cell-based glucose sensing and insulin delivery system$479,871
R01 · FY2004 · DK
Molecular Mechanisms of Autoimmune Heart Disease$468,735
R01 · FY2004 · HL
A cell-based glucose sensing and insulin delivery system$465,735
R01 · FY2003 · DK
A cell-based glucose sensing and insulin delivery system$466,689
R01 · FY2002 · DK
METABOLIC ENGINEERING OF SURRGOATE BETA CELLS$237,455
R01 · FY2002 · DK
BIOENGINEERING AN ARTIFICIAL BETA CELL$211,312
P01 · FY2002 · DK
Core--Transgenic$0
P30 · FY2002 · DK
METABOLIC ENGINEERING OF SURRGOATE BETA CELLS$230,541
R01 · FY2001 · DK
BIOENGINEERING AN ARTIFICIAL BETA CELL$211,312
P01 · FY2001 · DK
BIOENGINEERING AN ARTIFICIAL BETA CELL$180,000
P01 · FY2001 · DK
CORE--TRANSGENIC MOUSE FACILITY$123,636
P30 · FY2001 · DK
CORE--TRANSGENIC MOUSE FACILITY$0
P30 · FY2001 · DK
CORE--TRANSGENIC MOUSE FACILITY$0
P30 · FY2001 · DK
CORE--TRANSGENIC MOUSE FACILITY$0
P30 · FY2001 · DK
CORE--TRANSGENIC MOUSE FACILITY$0
P30 · FY2001 · DK
METABOLIC ENGINEERING OF SURRGOATE BETA CELLS$223,826
R01 · FY2000 · DK
CORE--TRANSGENIC MOUSE FACILITY$198,071
P30 · FY2000 · DK
BIOENGINEERING AN ARTIFICIAL BETA CELL$120,062
P01 · FY2000 · DK